NCT06376773View on ClinicalTrials.gov

Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.

CompletedOBSERVATIONAL
Enrollment

234

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

November 30, 2023

Conditions
Advanced Gastric CancerNeoadjuvant TherapyMulti-omics Analysis
Interventions
PROCEDURE

combination chemotherapy with Apatinib or Camrelizumab

Apatinib, chemotherapy alone, Camrelizumab

Trial Locations (1)

350000

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University

OTHER